Nifty

:

13258.55

Sensex

:

45079.55

124.65 (0.95%)
446.90 (1.00%)

Login

Nifty
Sensex

:
:

13258.55
45079.55

124.65 (0.95%)
446.90 (1.00%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

67/99

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

994.25

04-Dec-2020

Open
High
Low
Previous Close

981.05
1002.30
981.05
992.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

72685
721.25
1149.90
398.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,680.29
24.80
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,681.38
1.11%
4.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.14
7.58
7.87

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.98
12.88
13.65

PAT CAGR (%)

10 Years
5 Years
3 Years

6.92
11.04
25.28

P:E (Median)

8 Years
5 Years
3 Years

17.44
17.21
17.27

P:BV (Average)

8 Years
5 Years
3 Years

1.99
2.39
2.43

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.57
10.56
10.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 411.78 428.12 -3.82% 489.62 410.80 19.19% 416.86 379.15 9.95% 384.96 351.93 9.39%
Expenses 306.04 327.36 -6.51% 331.47 318.55 4.06% 325.73 319.23 2.04% 300.87 279.50 7.65%
EBITDA 105.74 100.76 4.94% 158.15 92.25 71.44% 91.14 59.92 52.10% 84.08 72.43 16.08%
EBIDTM 25.68% 23.54% 32.30% 22.46% -0.29% 15.80% 21.84% 20.58%
Other Income 8.19 18.11 -54.78% 22.54 12.34 82.66% 2.88 15.29 -81.16% 16.02 15.58 2.82%
Interest 1.70 0.87 95.40% 3.73 0.80 366.25% 0.40 1.31 -69.47% 0.85 1.27 -33.07%
Depreciation 17.14 16.22 5.67% 16.97 15.63 8.57% 16.69 11.41 46.28% 16.55 14.48 14.30%
PBT 95.09 101.77 -6.56% 159.99 88.16 81.48% 66.92 62.50 7.07% 82.70 72.26 14.45%
Tax 24.11 5.82 314.26% 38.07 29.01 31.23% 16.05 20.32 -21.01% 20.53 25.88 -20.67%
PAT 70.98 95.96 -26.03% 121.92 59.15 106.12% 50.87 42.18 20.60% 62.17 46.37 34.07%
PATM 17.24% 22.41% 24.90% 14.40% 2.87% 11.12% 16.15% 13.18%
EPS 9.18 12.41 -26.03% 15.77 7.65 106.14% 6.58 5.46 20.51% 8.04 6.00 34.00%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 443.56 456.42 -2.82% 522.29 446.11 17.08% 443.57 418.91 5.89% 428.63 382.03 12.20%
Expenses 333.47 356.16 -6.37% 366.86 350.13 4.78% 351.83 353.38 -0.44% 339.04 304.05 11.51%
EBITDA 110.10 100.26 9.81% 155.42 95.98 61.93% 91.74 65.54 39.98% 89.59 77.98 14.89%
EBIDTM 24.82% 21.97% 29.76% 21.51% 14.01% 15.65% 20.90% 20.41%
Other Income 8.39 18.51 -54.67% 22.69 12.61 79.94% 3.17 15.65 -79.74% 16.38 15.82 3.54%
Interest 1.72 0.87 97.70% 3.75 0.80 368.75% 0.50 1.31 -61.83% 0.85 1.30 -34.62%
Depreciation 17.45 16.39 6.47% 17.29 15.80 9.43% 17.39 11.60 49.91% 16.75 14.66 14.26%
PBT 99.33 101.51 -2.15% 157.07 91.99 70.75% 67.02 68.28 -1.85% 88.37 77.84 13.53%
Tax 25.41 7.75 227.87% 37.57 29.87 25.78% 16.95 21.49 -21.13% 21.93 27.89 -21.37%
PAT 73.92 93.76 -21.16% 119.51 62.11 92.42% 50.07 46.79 7.01% 66.45 49.95 33.03%
PATM 16.67% 20.54% 22.88% 13.92% 7.11% 11.17% 15.50% 13.08%
EPS 9.56 12.13 -21.19% 15.46 8.04 92.29% 6.48 6.05 7.11% 8.60 6.46 33.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,703.22 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 956.53 816.42 686.42 806.69 Net Sales Growth 8.49% 9.30% 19.62% 4.70% 2.90% 9.75% 10.97% 17.16% 18.94% -14.91% Cost Of Goods Sold 914.02 569.14 536.35 484.27 469.32 470.01 322.91 380.72 341.32 271.40 246.12 Gross Profit 789.20 1,071.61 964.83 770.72 729.38 694.93 738.51 575.81 475.10 415.02 560.57 GP Margin 46.34% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% 60.20% 58.19% 60.46% 69.49% Total Expenditure 1,264.11 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 802.49 705.00 622.22 638.78 Power & Fuel Cost - 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 23.34 % Of Sales - 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% 4.87% 4.87% 4.35% 2.89% Employee Cost - 293.78 257.98 217.31 187.86 165.96 146.82 131.85 120.13 101.31 116.43 % Of Sales - 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% 13.78% 14.71% 14.76% 14.43% Manufacturing Exp. - 129.40 139.89 130.97 122.68 119.24 223.30 102.28 61.62 52.90 60.66 % Of Sales - 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% 10.69% 7.55% 7.71% 7.52% General & Admin Exp. - 46.11 49.84 49.82 39.08 32.06 29.92 28.78 25.76 27.03 24.49 % Of Sales - 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% 3.01% 3.16% 3.94% 3.04% Selling & Distn. Exp. - 106.58 104.91 59.44 48.83 48.13 47.39 70.48 55.49 59.10 124.32 % Of Sales - 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% 7.37% 6.80% 8.61% 15.41% Miscellaneous Exp. - 65.96 60.48 72.71 57.49 48.54 45.12 41.78 60.93 80.59 124.32 % Of Sales - 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% 4.37% 7.46% 11.74% 5.38% EBITDA 439.11 368.24 288.44 182.20 218.54 225.73 192.94 154.04 111.42 64.20 167.91 EBITDA Margin 25.78% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% 16.10% 13.65% 9.35% 20.81% Other Income 49.63 49.57 40.23 56.21 49.51 55.68 10.41 37.54 25.96 28.51 5.88 Interest 6.68 3.16 4.57 3.41 5.00 10.29 6.65 5.93 5.24 21.78 10.19 Depreciation 67.35 65.09 54.82 55.95 46.26 40.41 37.60 27.17 24.40 22.30 22.65 PBT 404.70 349.56 269.28 179.04 216.78 230.69 159.10 158.49 107.74 48.63 140.95 Tax 98.76 71.42 87.22 51.04 43.82 51.49 45.52 25.56 22.81 166.52 22.76 Tax Rate 24.40% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% 27.19% 21.17% 20.58% 16.15% PAT 305.94 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 118.19 PAT before Minority Interest 305.94 268.14 182.06 128.00 172.96 179.20 113.58 68.43 84.94 642.70 118.19 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.96% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% 7.15% 10.40% 93.63% 14.65% PAT Growth 25.56% 47.28% 42.23% -25.99% -3.48% 57.77% 65.98% -19.44% -86.78% 443.79% EPS 39.58 34.69 23.55 16.56 22.38 23.18 14.69 8.85 10.99 83.14 15.29

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 1,838.05 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 1,021.86 866.13 801.87 890.79 Net Sales Growth 7.90% 8.00% 16.23% 3.32% 11.10% 7.64% 11.97% 17.98% 8.01% -9.98% Cost Of Goods Sold 5,114.53 630.80 596.46 542.41 552.00 491.41 341.40 413.95 371.52 320.07 277.04 Gross Profit -3,276.48 1,143.93 1,046.74 871.35 816.32 740.17 802.81 607.92 494.60 481.80 613.75 GP Margin -178.26% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% 59.49% 57.10% 60.08% 68.90% Total Expenditure 1,391.20 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 873.67 760.48 701.55 698.43 Power & Fuel Cost - 61.54 63.29 58.28 54.89 55.28 53.02 46.61 39.75 29.89 23.34 % Of Sales - 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% 4.56% 4.59% 3.73% 2.62% Employee Cost - 322.92 288.18 251.10 217.34 175.31 159.56 143.67 130.05 112.66 124.93 % Of Sales - 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% 14.06% 15.02% 14.05% 14.02% Manufacturing Exp. - 140.70 150.49 139.83 131.45 119.35 223.53 102.44 61.75 52.97 60.85 % Of Sales - 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% 10.02% 7.13% 6.61% 6.83% General & Admin Exp. - 48.89 52.97 53.96 42.26 34.82 32.46 31.69 27.94 31.31 38.21 % Of Sales - 2.75% 3.22% 3.82% 3.09% 2.83% 2.84% 3.10% 3.23% 3.90% 4.29% Selling & Distn. Exp. - 116.95 113.59 87.44 78.27 72.72 75.13 73.59 56.04 68.65 131.60 % Of Sales - 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% 7.20% 6.47% 8.56% 14.77% Miscellaneous Exp. - 75.36 72.38 81.61 59.72 76.65 79.01 61.72 73.44 86.00 131.60 % Of Sales - 4.25% 4.40% 5.77% 4.36% 6.22% 6.91% 6.04% 8.48% 10.72% 4.77% EBITDA 446.85 377.58 305.84 199.13 232.39 206.03 180.12 148.19 105.65 100.32 192.36 EBITDA Margin 24.31% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% 14.50% 12.20% 12.51% 21.59% Other Income 50.63 50.90 41.44 55.29 50.16 56.65 10.89 37.70 27.87 28.98 6.16 Interest 6.82 3.26 4.65 3.49 5.37 10.65 6.82 5.93 5.28 24.03 10.49 Depreciation 68.88 66.32 55.64 56.97 47.22 41.22 38.64 28.02 24.66 22.42 22.79 PBT 411.79 358.89 286.99 193.95 229.94 210.82 145.55 151.94 103.57 82.85 165.24 Tax 101.86 76.50 93.02 55.23 45.55 49.58 45.14 25.95 24.13 165.53 25.92 Tax Rate 24.74% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% 29.68% 23.30% 19.63% 15.69% PAT 309.95 272.04 193.47 138.34 184.06 161.14 100.41 61.50 79.44 677.91 139.32 PAT before Minority Interest 309.60 272.39 193.97 138.72 184.40 161.24 100.41 61.50 79.44 677.91 139.32 Minority Interest -0.35 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.86% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% 6.02% 9.17% 84.54% 15.64% PAT Growth 22.70% 40.61% 39.85% -24.84% 14.22% 60.48% 63.27% -22.58% -88.28% 386.58% EPS 40.10 35.19 25.03 17.90 23.81 20.85 12.99 7.96 10.28 87.70 18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 1,047.81 1,009.00 953.86 713.28 Share Capital 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 16.90 Total Reserves 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 1,030.82 991.95 936.74 696.05 Non-Current Liabilities 73.29 79.08 62.98 41.79 46.07 34.05 32.56 37.45 36.35 33.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 0.54 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 11.12 11.49 Long Term Provisions 7.39 5.73 9.67 8.88 10.20 12.03 12.19 8.23 8.27 6.88 Current Liabilities 493.12 763.27 711.89 666.97 735.89 398.40 261.56 226.38 182.51 260.64 Trade Payables 111.35 111.33 100.22 79.03 68.61 62.31 51.69 51.76 33.54 44.36 Other Current Liabilities 138.29 87.05 112.90 118.08 119.03 82.60 94.00 98.41 76.70 55.70 Short Term Borrowings 32.04 25.80 28.48 48.86 174.40 104.73 81.28 36.77 55.23 133.36 Short Term Provisions 211.45 539.10 470.29 421.00 373.85 148.76 34.59 39.43 17.05 27.22 Total Liabilities 2,011.70 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72 1,007.27 Net Block 583.21 552.11 569.91 608.69 369.35 300.87 282.21 294.37 241.01 225.20 Gross Block 1,105.15 1,011.81 979.68 963.76 679.77 571.73 510.94 497.02 421.06 386.76 Accumulated Depreciation 521.95 459.70 409.78 355.07 310.42 270.86 228.74 202.65 180.05 161.57 Non Current Assets 805.74 804.94 781.26 941.36 891.59 604.38 378.00 352.44 331.38 283.34 Capital Work in Progress 16.17 15.09 17.40 3.76 134.89 55.17 46.32 4.81 39.00 3.75 Non Current Investment 202.42 228.84 182.92 318.81 364.38 230.72 38.86 38.98 38.79 42.24 Long Term Loans & Adv. 3.59 8.31 10.00 9.22 22.63 17.62 10.62 14.28 12.58 12.16 Other Non Current Assets 0.36 0.59 1.03 0.88 0.33 0.00 0.00 0.00 0.00 0.00 Current Assets 1,205.97 1,521.97 1,446.99 1,155.26 1,113.08 844.38 963.93 920.39 841.34 723.92 Current Investments 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 81.05 Inventories 232.04 208.10 175.81 159.96 133.29 128.47 111.23 89.89 90.80 81.78 Sundry Debtors 344.24 299.85 300.54 265.10 265.67 248.49 248.05 194.64 131.21 385.45 Cash & Bank 11.56 20.77 14.95 7.20 10.71 9.06 10.80 149.11 211.36 122.92 Other Current Assets 284.31 32.49 11.20 12.23 456.13 91.58 96.59 92.07 109.05 52.72 Short Term Loans & Adv. 266.71 600.11 560.72 485.82 453.62 91.20 96.39 91.92 108.65 51.97 Net Current Assets 712.84 758.71 735.10 488.29 377.19 445.98 702.37 694.01 658.83 463.29 Total Assets 2,011.71 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76 1,341.93 1,272.83 1,172.72 1,007.26

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 1,042.81 1,020.27 969.95 691.54 Share Capital 15.46 16.05 16.71 16.96 16.96 16.96 16.95 16.94 16.94 16.90 Total Reserves 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 1,025.82 1,003.22 952.83 674.31 Non-Current Liabilities 62.72 64.84 45.66 26.98 31.02 32.62 31.93 40.45 39.52 36.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.22 0.40 0.54 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.40 0.40 7.03 12.14 11.99 Long Term Provisions 7.39 5.73 9.67 12.56 10.43 12.03 12.19 8.23 8.27 7.71 Current Liabilities 515.77 781.54 736.50 693.46 797.22 459.75 276.27 239.48 188.32 271.33 Trade Payables 123.79 117.37 110.39 98.98 90.85 77.51 60.75 60.51 37.09 50.21 Other Current Liabilities 143.88 93.10 119.75 122.15 138.73 103.74 98.06 101.15 78.75 61.22 Short Term Borrowings 32.04 25.80 29.29 48.86 193.02 126.88 81.71 37.28 55.23 133.36 Short Term Provisions 216.06 545.27 477.06 423.47 374.61 151.62 35.76 40.54 17.26 26.54 Total Liabilities 2,016.48 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 1,351.01 1,300.20 1,197.79 999.37 Net Block 651.26 620.93 639.50 679.44 440.22 328.56 310.55 334.41 276.31 258.39 Gross Block 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 540.54 537.46 456.51 420.25 Accumulated Depreciation 526.17 463.89 414.25 359.10 313.53 273.11 229.99 203.06 180.19 161.85 Non Current Assets 740.83 740.80 717.89 879.15 831.58 586.31 370.37 356.49 331.58 278.78 Capital Work in Progress 16.17 15.09 17.40 3.76 134.89 55.17 46.36 4.81 39.00 3.75 Non Current Investment 69.45 95.88 49.96 185.84 231.42 184.83 2.75 2.99 3.00 3.94 Long Term Loans & Adv. 3.59 8.31 10.15 9.43 22.63 17.74 10.71 14.28 13.27 12.70 Other Non Current Assets 0.36 0.59 0.88 0.67 2.43 0.00 0.00 0.00 0.00 0.00 Current Assets 1,275.65 1,588.51 1,508.59 1,207.14 1,182.16 900.94 980.65 943.71 866.22 720.60 Current Investments 333.81 360.65 383.77 224.96 247.28 366.78 497.26 394.68 298.92 81.05 Inventories 274.67 243.76 213.73 200.17 187.98 150.27 134.40 104.53 101.03 111.67 Sundry Debtors 345.43 308.22 300.73 265.97 272.64 262.35 235.51 191.27 136.05 345.58 Cash & Bank 30.95 36.80 29.92 13.39 12.90 25.19 11.81 156.23 219.53 126.89 Other Current Assets 290.80 33.23 12.94 14.36 461.34 96.35 101.68 96.99 110.69 55.41 Short Term Loans & Adv. 272.33 605.85 567.50 488.30 458.83 95.97 101.48 96.84 110.29 54.66 Net Current Assets 759.88 806.97 772.10 513.68 384.94 441.19 704.37 704.23 677.90 449.27 Total Assets 2,016.48 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25 1,351.02 1,300.20 1,197.80 999.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 271.57 192.63 115.87 177.58 170.87 143.03 -11.65 80.41 850.80 136.83 PBT 339.56 269.28 179.04 216.78 230.69 159.10 93.99 107.74 809.22 141.05 Adjustment 15.19 26.87 14.73 10.01 -9.63 35.94 14.11 -6.43 3.51 23.67 Changes in Working Capital 3.97 -42.44 -39.95 -0.30 1.15 -14.04 -93.19 0.67 202.58 1.62 Cash after chg. in Working capital 358.72 253.70 153.82 226.50 222.22 181.00 14.90 101.98 1,015.31 166.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 -26.55 -21.57 -164.51 -29.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.18 -27.93 -23.97 -42.45 -51.69 -121.72 -138.77 -111.73 -235.86 -89.41 Net Fixed Assets -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 -32.72 Net Investments 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 -60.83 Others 65.34 24.69 28.51 42.52 150.23 9.30 19.12 25.99 48.11 4.14 Cash from Financing Activity -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 12.12 -30.93 -526.49 4.93 Net Cash Inflow / Outflow -9.73 9.05 32.45 -29.71 21.72 -1.75 -138.31 -62.25 88.44 52.35 Opening Cash & Equivalents 16.11 7.09 -25.36 4.35 -14.50 10.80 149.11 211.36 122.92 70.57 Closing Cash & Equivalent 6.37 16.11 7.09 -25.36 7.23 9.06 10.80 149.11 211.36 122.92

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 275.37 194.33 122.92 201.13 140.41 126.66 -13.98 84.20 879.69 133.92 PBT 348.89 286.99 193.95 229.94 212.23 145.55 87.44 103.57 843.44 165.34 Adjustment 7.95 23.72 16.91 13.11 -1.40 38.51 20.75 -4.40 33.13 16.60 Changes in Working Capital 9.32 -51.47 -47.07 5.92 -16.96 -19.52 -93.71 9.47 167.35 -15.87 Cash after chg. in Working capital 366.17 259.24 163.79 248.97 193.88 164.53 14.49 108.65 1,043.91 166.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 -28.47 -24.45 -164.22 -32.15 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.30 -27.67 -20.68 -45.31 -27.62 -111.89 -142.50 -116.05 -260.92 -89.46 Net Fixed Assets -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 -55.43 -41.77 -69.55 -32.72 Net Investments 53.26 -22.80 -22.92 67.89 -14.16 -61.38 -102.46 -95.95 -214.42 -60.83 Others 65.46 24.95 31.80 39.66 174.30 19.13 15.39 21.67 23.05 4.09 Cash from Financing Activity -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 12.04 -31.45 -526.12 4.56 Net Cash Inflow / Outflow -6.38 10.92 42.72 -28.02 13.17 13.38 -144.43 -63.30 92.65 49.02 Opening Cash & Equivalents 32.14 21.24 -21.47 6.54 -5.46 11.81 156.23 219.53 126.89 77.86 Closing Cash & Equivalent 25.75 32.14 21.24 -21.47 9.42 25.19 11.81 156.23 219.53 126.89

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 187.02 185.02 173.91 163.62 144.15 119.84 123.66 119.10 112.59 84.36 ROA 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% 5.23% 6.95% 58.96% 12.59% ROE 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% 6.65% 8.66% 77.13% 17.83% ROCE 22.94% 18.30% 12.50% 15.65% 19.14% 14.65% 9.09% 10.85% 87.21% 18.53% Fixed Asset Turnover 1.55 1.51 1.29 1.46 1.86 1.99 1.92 1.80 1.72 2.18 Receivable days 71.64 72.99 82.25 80.81 80.55 84.22 83.37 71.93 135.90 177.98 Inventory Days 48.96 46.67 48.83 44.65 41.01 40.66 37.88 39.88 45.40 31.03 Payable days 33.20 32.65 32.75 29.00 27.03 25.03 24.67 24.46 26.27 27.04 Cash Conversion Cycle 87.40 87.01 98.33 96.46 94.52 99.85 96.57 87.35 155.03 181.96 Total Debt/Equity 0.02 0.02 0.02 0.04 0.14 0.10 0.09 0.05 0.07 0.24 Interest Cover 108.34 59.98 53.45 44.35 23.41 24.93 16.84 21.55 38.16 14.84

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 185.75 184.47 172.50 160.77 139.57 117.31 123.07 119.21 113.34 80.86 ROA 12.54% 8.52% 6.43% 8.99% 9.21% 7.08% 4.64% 6.36% 61.71% 15.17% ROE 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% 5.99% 8.07% 82.49% 22.35% ROCE 23.69% 19.59% 13.70% 16.87% 17.72% 13.49% 8.50% 10.41% 92.09% 22.63% Fixed Asset Turnover 1.57 1.54 1.35 1.53 1.82 2.03 1.92 1.76 1.85 2.22 Receivable days 67.22 67.63 73.15 71.84 79.28 78.41 75.30 68.16 108.62 140.48 Inventory Days 53.31 50.81 53.43 51.77 50.12 44.83 42.16 42.80 47.97 39.77 Payable days 32.74 32.21 33.66 32.86 32.45 27.82 26.91 26.15 26.89 25.89 Cash Conversion Cycle 87.79 86.23 92.93 90.75 96.95 95.43 90.54 84.81 129.69 154.35 Total Debt/Equity 0.02 0.02 0.02 0.04 0.16 0.13 0.09 0.05 0.07 0.25 Interest Cover 108.09 62.74 56.54 43.81 20.80 22.33 15.74 20.61 36.10 16.75

Top Investors:

dsp small cap fund **

franklin india smaller companies fund

hdfc small cap fund **

icici prudential pharma healthcare and diaganostics (p.h.d) fund **

Annual Reports:

News Update:

CCI approves proposal of Tau Investment to acquire shares in JB Chemicals
27th Aug 2020, 12:35 PM

The proposed combination envisages acquisition of up to 64.90% of the share capital of JB Chemicals & Pharmaceuticals by Tau Investment
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback